Breathing life into Australian diabetes clinical guidelines

Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce

“…The living guideline approach ensures that new, important evidence is rapidly translated into clinical recommendations, without compromising quality or rigour of guideline development. While living guidelines methods have been successfully applied to Australian guidelines on stroke and diabetes, 18,83 the approach of weekly updating used by this Taskforce is the most frequent of which we are aware. While resource‐intensive, the collaborative effort of over 220 clinical experts nationwide, as well as support from commonwealth, state and territory governments and other funders, has shown this model to be highly feasible in the context of a global public health emergency.…”

“…17 This approach has been used successfully in stroke, diabetes, maternal health and other topics. [18][19][20] The National COVID-19 Clinical Evidence Taskforce was established in March 2020 to produce living recommendations on the clinical care of people with COVID-19 in Australia. 21 As of 17…”

“…In living guidelines, digital technologies and continuous evidence surveillance are used to continually update systematic reviews and recommendations, so as to reflect the latest available evidence 17 . This approach has been used successfully in stroke, diabetes, maternal health and other topics 18–20 …”

Clinical guidelines for caring for women with COVID-19 during pregnancy, childbirth and the immediate postpartum period

“…In the living guidelines approach, literature is monitored on an ongoing basis, with systematic reviews, evidence profiles and recommendations updated in response to changes in the underlying evidence. Living guideline approaches have been applied in guidelines for maternal and perinatal health, stroke and diabetes [93][94][95]. In March 2020, the National COVID-19 Clinical Evidence Taskforce (https://covid19evidence.net.au/) was established in Australia to provide healthcare professionals with living guidelines on the clinical care of people with COVID-19.…”

Awareness, value and use of the Australian living guidelines for the clinical care of people with COVID-19: an impact evaluation

“…A small but increasing number of living guideline projects are underway, including in stroke, diabetes, arthritis, maternal health and the recent living WHO guideline on drugs for COVID-19 [2] , [3] , [4] , [5] , however little is currently known about the characteristics of the development or dissemination of these guidelines that make them more or less likely to succeed in having impact.…”